Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (691)	8/4/2004 5:38:03 PM
From: hmpa	Read Replies (1) of 897

I'd suggest a glance at CNCT. I listened to the quarterly cc and in response to direct analysts' question regarding possible generic competition to Soriatane whoever was fielding the call boldly claimed they don't know about any even in the future. OTOH, googling the combination "ranbaxy soriatane ANDA" gives a neat table showing that the said company plans to launch generic in the US in 2004 and make same $10MM off it. Either CNCT guys have no clue about competition or for that matter using Internet or are lying through their teeth.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next